Member has chronic pulmonary disease (including alpha-1 antitrypsin deficiency, asbestosis, asthma, emphysema, chronic airflow obstruction, chronic bronchitis, cystic fibrosis, fibrosing alveolitis, pneumoconiosis, pulmonary alveolar proteinosis, pulmonary fibrosis, pulmonary hemosiderosis, persistent pulmonary im...
Diastolic cardiomyopathy secondary to experimentally induced exacerbated emphysema. Am J Respir Cell Mol Biol. 2023;69(2):230–41. Article PubMed CAS Google Scholar Rahman HH, Rashid MH, Miah NA, Israt S, Atiqullah S, Akbar MS. Correlation study between COPD and heart failure in elderly ...
Patients were included if they were: older than 45 years of age; admitted to hospital between March 1, 2013 to March 31, 2015 with an International Classification of Diseases, Tenth Revision (ICD-10-CA) code indicative of AECOPD (J42 [unspecified chronic bronchitis], J43 [emphysema], or ...
COPD is characterized by chronic bronchitis, chronic airway obstruction, and emphysema, which causes progressive, irreversible decline in lung function3. COPD patients with acute exacerbation need to be admitted to the hospital with a mortality rate of approximately 10%4. Inflammatory cells infiltrate ...
COPD-related hospitalization was defined based on International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) codes (491.xx–Chronic bronchitis; 492.xx–Emphysema; 493.2x–Chronic obstructive asthma, or 496-Chronic airway obstruction, not elsewhere classified). Patients were...
selected from the database. The definition of AECOPD was determined using the AECOPD ICD-9-CM code 491.21. For patients with multiple hospitalizations, only the first hospitalization was enrolled. The exclusion criteria included: age<18 years, length of ICU stay <48 h, or missing data >10%....
Eligible patients were ≥40 years of age with incident NHI disease claims relevant to COPD or asthma (COPD, ICD-9-CM codes: 491 [chronic bronchitis], 492 [emphysema] or 496 [chronic airway obstruction, not elsewhere classified]; asthma, ICD-9-CM code: 493 [asthma]). A disease was consi...
0.01 mg/kg of Am80-encapsulated SS-OP nanoparticles repaired collapsed alveoli and improved the respiratory function in the mouse model of elastase induced emphysema. The results suggested that, with the use of SS-OP, the Am80 dose could be reduced. This could contribute to the development of...